EC Number |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
---|
1.3.1.74 | Neoplasms |
14977853 |
NADPH alkenal/one oxidoreductase activity determines sensitivity of cancer cells to the chemotherapeutic alkylating agent irofulven. |
ongoing research therapeutic application unassigned |
3 2 0 |
1.3.1.74 | Neoplasms |
16857669 |
Nrf2-mediated induction of cytoprotective enzymes by 15-deoxy-Delta12,14-prostaglandin J2 is attenuated by alkenal/one oxidoreductase. |
therapeutic application unassigned |
4 0 |
1.3.1.74 | Neoplasms |
24853774 |
Increased expression of prostaglandin reductase 1 in hepatocellular carcinomas from clinical cases and experimental tumors in rats. |
causal interaction ongoing research unassigned |
4 2 0 |